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ABSTRACT
RIEBE, D., B. A. FRANKLIN, P. D. THOMPSON, C. E. GARBER, G. P. WHITFIELD, M. MAGAL, and L. S. PESCATELLO.
Updating ACSM_s Recommendations for Exercise Preparticipation Health Screening.Med. Sci. Sports Exerc., Vol. 47, No. 8, pp. 2473–2479,
2015. The purpose of the American College of Sports Medicine_s (ACSM) exercise preparticipation health screening process is to
identify individuals who may be at elevated risk for exercise-related sudden cardiac death and/or acute myocardial infarction. Recent
studies have suggested that using the current ACSM exercise preparticipation health screening guidelines can result in excessive phy-
sician referrals, possibly creating a barrier to exercise participation. In addition, there is considerable evidence that exercise is safe for
most people and has many associated health and fitness benefits; exercise-related cardiovascular events are often preceded by warning
signs/symptoms; and the cardiovascular risks associated with exercise lessen as individuals become more physically active/fit. Conse-
quently, a scientific roundtable was convened by the ACSM in June 2014 to evaluate the current exercise preparticipation health
screening recommendations. The roundtable proposed a new evidence-informed model for exercise preparticipation health screening on
the basis of three factors: 1) the individual_s current level of physical activity, 2) presence of signs or symptoms and/or known cardio-
vascular, metabolic, or renal disease, and 3) desired exercise intensity, as these variables have been identified as risk modulators of
exercise-related cardiovascular events. Identifying cardiovascular disease risk factors remains an important objective of overall disease
prevention and management, but risk factor profiling is no longer included in the exercise preparticipation health screening process. The
new ACSM exercise preparticipation health screening recommendations reduce possible unnecessary barriers to adopting and main-
taining a regular exercise program, a lifestyle of habitual physical activity, or both, and thereby emphasize the important public health
message that regular physical activity is important for all individuals. Key Words: PRESCREENING, SUDDEN CARDIAC DEATH,
PHYSICAL ACTIVITY, CARDIOVASCULAR DISEASE
R
egular physical activity and structured exercise are
associated with numerous health benefits including a
lower risk of cardiovascular disease (CVD), type
2 diabetes mellitus, some forms of cancer, and age-adjusted
all-cause mortality, among others (19,26,33,43). Despite
these well-known health benefits, physical inactivity is a
global pandemic that has been identified as one of the
four leading contributors to premature mortality (22,26).
Although efforts to promote physical activity at both the
individual and community level have had some success, the
prevalence of physical inactivity remains high (7,8,36,50).
Physical activity is a complex behavior influenced by demo-
graphic, biological, cognitive, emotional, sociocultural, and
environmental factors (3). Accordingly, individuals face nu-
merous barriers in both the adoption and maintenance of
a regular exercise program, as evidenced by high levels of
physical inactivity (2,3).
A possible barrier to becoming physically active is the
requirement for exercise preparticipation health screening,
which may involve a visit to a health care provider and/or
diagnostic testing to potentially identify underlying CAD
and other occult CVD (3,16,46). Unnecessary referral to
health care providers for screening may lead to a high rate of
false-positive exercise test responses in some populations,
necessitating medical follow-up and additional noninvasive/
invasive studies when they are not needed. Such studies can
place unnecessary financial and other burdens on the indi-
vidual and health care system (16,32). Vigorous-intensity
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exercise does have a small but measurable acute risk of CVD
complications; therefore, mitigating this risk in susceptible
individuals is important (31,39,40). The exercise prepar-
ticipation health screening process should provide prudent
assessment while minimizing barriers to adopting a physically
active lifestyle.
The existing American College of Sports Medicine (ACSM)
exercise preparticipation health screening recommendations
stipulate that persons at moderate risk for CVD undergo a
medical examination prior to starting a vigorous (achieving
Q60% oxygen uptake reserve (V˙O2R) or heart rate (HR)
reserve (HRR), or Q6 METs) exercise program (2,19). An
individual is considered at moderate risk for CVD if he/she
is asymptomatic and has two or more CVD risk factors (2).
ACSM also recommends that persons at high risk for CVD
undergo a medical examination and diagnostic exercise test-
ing before beginning either a moderate-intensity (40% to G60%
V˙O2R or HRR; 3 to G6 METs) or a vigorous-intensity exercise
program. Lastly, an individual is considered at high risk for
CVD if they are symptomatic or have known cardiovascular,
pulmonary, metabolic, or renal disease (2).
The current ACSM exercise preparticipation health screenng
recommendations were largely formulated to reduce the like-
lihood of ‘‘at-risk’’ individuals experiencing serious exercise-
related cardiovascular events, including sudden cardiac death
(SCD) and/or acute myocardial infarction (AMI). Although
the risk of an acute cardiovascular event is transiently in-
creased during vigorous-intensity exercise relative to rest,
especially in habitually sedentary individuals with known or
occult CVD who engage in unaccustomed strenuous physical
exertion, the absolute and relative risks of a cardiovascular
event during exercise are extremely low even during vigorous-
intensity exercise in asymptomatic individuals (35,39,41).
In addition, the risk of an acute cardiovascular event decreases
with increasing volumes of regular exercise (31,39) and among
people who are physically fit (40). Finally, recent reports have
suggested that using current prescreening algorithms can re-
sult in excessive referrals to physicians for medical clearance,
which could be a barrier to adopting and maintaining a reg-
ular exercise program (24,45,48).
Because motivating people to be physically active is a
significant challenge, exercise preparticipation health screen-
ing recommendations should not present unnecessary obsta-
cles that deter people from adopting and maintaining a regular
exercise program. In addition, because of increasing evidence
that exercise is safe for most people, it has many associated
health benefits, exercise-related cardiovascular events are
often preceded by warning signs/symptoms, and the car-
diovascular risks associated with exercise lessen as people
become more physically active/fit, leading experts from the
College recognized the need for evaluation and refinement
of the existing ACSM preparticipation health screening
recommendations (5,19,40,44). Accordingly, in June 2014,
the ACSM convened a scientific roundtable (i.e., expert panel)
to establish best practices in the exercise preparticipation
health screening process.
The scientific roundtable consisted of experts in risk as-
sessment, preventive cardiology, general cardiology, public
health, exercise physiology, and geriatrics as well as prac-
titioners from the fields of medicine, clinical exercise
physiology, and health fitness/prevention. After a review of
the scientific literature and extensive discussion, members
of the roundtable proposed an evidence-informed model for
the new ACSM exercise preparticipation health screening
recommendations described in this consensus statement. In
this consensus statement, we present the new ACSM exer-
cise preparticipation health screening recommendations,
summarize the changes that were made from the previous
ACSM recommendations, and provide the fundamental phys-
iological and clinical reasons for the changes that were
made. The new ACSM recommendations are not a replace-
ment for sound clinical judgment, and decisions about re-
ferral to a health care provider for medical clearance before
the initiation of an exercise program should continue to be
made on an individual basis.
THE NEW ACSM EXERCISE
PREPARTICIPATION HEALTH
SCREENING RECOMMENDATIONS
The goals of the new ACSM exercise preparticipation
health screening process are to identify individuals 1) who
should receive medical clearance before initiating an exer-
cise program or increasing the frequency, intensity, and/or
volume of their current program, 2) with clinically significant
disease(s) who may benefit from participating in a medically
supervised exercise program, and 3) with medical conditions
that may require exclusion from exercise programs until those
conditions are abated or better controlled (2).
The new ACSM exercise preparticipation health screen-
ing recommendations differ from previous recommenda-
tions in several ways (Table 1). CVD risk factor assessment
and risk classification are no longer part of the exercise
preparticipation health screening process per se. Instead, the
TABLE 1. Summary of major changes in ACSM_s exercise preparticipation health screening procedures.
 The previous ACSM exercise preparticipation health screening process was based on the following: 1) the number of CVD risk factors and 2) presence of signs or symptoms and/or
known cardiovascular, metabolic, renal, and/or pulmonary disease. The new ACSM exercise preparticipation health screening process is now based on the following: 1) the
individual_s current level of physical activity, 2) presence of signs or symptoms and/or known cardiovascular, metabolic, or renal disease, and 3) desired exercise intensity, as
these three factors have been identified as important risk modulators of exercise-related cardiovascular events.
 Identifying and controlling CVD risk factors continue to be important objectives of overall cardiovascular and metabolic disease prevention and management; however, the CVD risk
factor profile is no longer included in the decision making for referral to a health care provider before initiating a moderate- to vigorous-intensity exercise program.
 The classification of individuals as having low, moderate, or high risk of CVD is no longer included in the new ACSM exercise preparticipation health screening process. Specific
recommendations for a medical examination or exercise testing based on risk classification is no longer included. Instead, individuals are referred to their health care provider for
medical clearance, defined as approval from a health care professional to engage in exercise.
 Individuals with pulmonary disease are not automatically referred for medical clearance before initiation of an exercise program.
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new ACSM exercise preparticipation health screening pro-
cess focuses on 1) the individual_s current level of physical
activity, 2) presence of signs or symptoms of known cardio-
vascular, metabolic, or renal disease, and 3) the desired exer-
cise intensity, as these variables have been identified as risk
modulators of exercise-related cardiovascular events (2,6,19).
Several key findings formed the rationale for the current
changes outlined in Table 1. They are presented as follows.
Risk of SCD and AMI. It is well established that the
transient risks of SCD and AMI are substantially higher
during acute vigorous physical exertion as compared with
those during rest (1,31). Retrospective and prospective data
suggest that vigorous-intensity physical activity transiently
increases the risk of nonfatal AMI and SCD approxi-
mately sixfold (31) to 17-fold (1) as compared with rest-
ing behavior.
Although the relative risks of SCD and AMI are higher
during sudden vigorous physical exertion versus those at
rest, the absolute risk of these events is very low. Prospec-
tive evidence from the Physicians_ Health Study and Nurses_
Health Study suggests that SCD occurs every 1.5 million
episodes of vigorous physical exertion in men (1) and every
36.5 million hours of moderate-to-vigorous exertion in
women (47). Retrospective analyses also support the rarity
of these events. Thompson et al. (41) reported one death per
396,000 h of jogging. An analysis of exercise-related car-
diovascular events among participants at YMCA sports
centers found one death per 2,897,057 person-hours, al-
though exercise intensity was not documented (30). Kim
et al. (25) studied more than 10 million marathon and half-
marathon runners and identified an overall cardiac arrest
incidence rate of one per 184,000 runners and an SCD in-
cidence rate of one per 256,000 runners, which translate to
0.20 cardiac arrests and 0.14 SCD per 100,000 estimated
runner-hours. Collectively, these studies illustrate the rarity of
CVD events during exercise and suggest that exercise is safe for
most people. Because there are few data regarding cardiovas-
cular complications during resistance training, this risk can-
not currently be determined but seems to be low (20,21,49).
Research into exercise-related SCD and AMI has revealed
several variables associated with increased risk of cardiovas-
cular events. Exercise-related cardiovascular events are often
preceded bywarning signs or symptoms (40). Autopsy studies
of those who experienced SCD suggest that underlying CAD
contributed to most cases among adults age 35 yr and older,
whereas exertion-related SCD in younger people is often at-
tributed to structural cardiovascular abnormalities, most no-
tably, hypertrophic cardiomyopathy (27). However, research
on exercise-associated SCD and AMI has focused primarily
on the effects of vigorous- to near maximal-intensity physical
activity (35). Less is known about the risks of SCD and AMI
during light- to moderate-intensity exercise, but they are as-
sumed to be substantially lower (44). Moreover, in virtually
all studies, habitual physical activity was inversely related to
the likelihood of SCD and/or AMI occurring during or im-
mediately after vigorous-intensity exercise (1,12,31,39).
Although increasing age is a risk factor for CVD (men,
Q45 yr; women, Q55 yr), there is no evidence that age per se is
a strong predictor of exercise-associated SCD and AMI (20),
and the referral of individuals for medical clearance solely on
the basis of age has been shown to result in superfluous health
care referrals (6,19,46).
Physical activity status. Physically inactive individuals
are at greater total risk for acute cardiac events than their
physically active counterparts (18,44). To put the risk versus
protective benefit of exercise into perspective, it is important
to reemphasize that the absolute risk of exercise-related acute
cardiac events is extremely low. The relative risk of SCD and
AMI during vigorous- to near maximal-intensity exercise
is directly related to the presence of CVD and/or exertional
symptoms and inversely related to the individual_s habitual
level of physical activity. For example, the Onset Study (31)
showed that the risk of AMI during vigorous intensity exer-
cise was almost twice that at rest even for individuals who
exercised vigorously for 1 h on 5 or more days per week. How-
ever, this study also showed that the risk of AMI for habitu-
ally inactive individuals was 50 times higher than that for the
most physically active individuals (Fig. 1). Regular exercise
reduces the 24-h risk of CVD events by approximately 50%
(4,34), meaning that the regular exerciser_s relative risk is
significantly lower during both vigorous-intensity exercise
and over the remainder of the day, highlighting the clear net
benefit of regular physical activity.
A recent meta-analysis reported a fivefold increased risk
of SCD and 3.5-fold increased risk of AMI during vigorous-
intensity physical activity (Q6 METs) (12). However, in
cohorts with the lowest habitual physical activity levels, the
FIGURE 1—Relative risk of AMI at rest (baseline risk) and during
vigorous physical activity (Q6 METs) in sedentary and physically active
individuals, with specific reference to the habitual frequency of vigor-
ous exertion (dIwkj1). (Adapted from Mittleman MA, Maclure M,
Tofler GH, Sherwood JB, Goldberg RJ, Muller JE. Triggering of acute
myocardial infarction by heavy physical exertion. Protection against
triggering by regular exertion. Determinants of Myocardial Infarction
Onset Study Investigators. N Engl J Med. 1993;329(23):1677–1683.
Used with permission. Adapted from Franklin BA. Preventing exercise-
related cardiovascular events: is a medical examination more urgent
for physical activity or inactivity? Circulation. 2014;129:1081–1084.
Used with permission.)
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relative risk for exertion-related AMI ranged from 4.5 to 107,
indicating a substantial increased risk in physically inactive
individuals; in contrast, the corresponding relative risk in the
groups with the highest habitual physical activity levels was
only 0.86–3.3, suggesting much smaller increases in risk in
active individuals. Furthermore, these authors found that for
every additional exercise bout per week, there was 30% re-
duction in the risk of SCD and 45% reduction in the risk of
AMI during physical activity (12).
The previously referenced findings are consistent with the
conclusion of the 2008 Physical Activity Guidelines Advisory
Committee and ACSM that the overall cardiovascular ben-
efits of regular physical activity far outweigh the modestly
increased acute exercise risks (44). These findings are also
consistent with the recommendations of Bredin et al. (6)
and Warburton et al. (46). Collectively, these studies sug-
gest that the risk of exercise is highest among inactive in-
dividuals and those with known or occult CAD who perform
unaccustomed vigorous-intensity physical activity.
CVD risk factor assessment. Two important consid-
erations led to removing CVD risk factor assessment from the
new ACSM exercise preparticipation health screening pro-
cess. First, the high prevalence of CVD risk factors among
adults, combined with the extreme rarity of exercise-related
SCD and AMI, suggests that the ability to predict these rare
events by assessing CVD risk factors is low (42). For exam-
ple, the Centers for Disease Control and Prevention estimate
that 65million US adults have hypertension (11) and 71 million
adults have high LDL cholesterol (9). In contrast, 600,000
people die from heart disease each year and only a small
fraction of those are due to exercise-associated SCD and
AMI (10). Therefore, using CVD risk factors to identify
those susceptible to exercise-associated SCD or AMI as
ACSM has done in the past is unlikely to be effective in
achieving its intended purpose. Second, recent evidence
suggests that conventional CVD risk factor-based exercise
preparticipation health screening may be overly conserva-
tive because of the high prevalence of CVD risk factors. A
recent study found that 95% of men and women over 40 yr
of age would be advised to consult a physician before exer-
cise based upon the previous risk factor-based exercise pre-
participation health screening process (48).
Identifying and controlling CVD risk factors continue
to be important objectives of overall cardiovascular and
metabolic disease prevention and management, and exercise
professionals are encouraged to complete a CVD risk fac-
tor assessment with their patients/clients (2,14). However,
risk factor profiling is no longer included in the exercise
preparticipation health screening process as a determinant of
medical clearance for exercise. Nonetheless, some evidence
suggests that diabetes mellitus and renal disease may be
associated with exercise-related SCD and AMI (1,31), and
specific recommendations for individuals with these co-
morbid conditions are incorporated into the new procedures.
Risk classification and medical clearance. The
previous ACSM exercise preparticipation health screening
recommendations classified individuals as having low, moder-
ate, or high risk for CVD on the basis of the number of CVD
risk factors and the presence of signs or symptoms and/or car-
diovascular, metabolic, renal, or pulmonary disease (2). The
recommendation for a medical examination or diagnostic ex-
ercise test before engaging in exercise was then based on this
risk classification scheme. Because CVD risk factor profiling
has been removed as part of the new ACSM exercise prepar-
ticipation health screening process, individuals no longer need
to be classified into risk categories. Instead, individuals are
referred to health care providers for medical clearance, defined
as approval from a health care professional to engage in exer-
cise, on the basis of the presence of signs or symptoms and/or
known cardiovascular, metabolic, or renal disease and physical
activity status. The term ‘‘medical clearance’’ has replaced
specific recommendations for a medical examination or ex-
ercise test because it should be the health care provider who
decides what evaluation, if any, is appropriate before the ini-
tiation of a moderate- to vigorous-intensity exercise program.
There is a lack of evidence that medical clearance and
exercise testing (28) are effective in mitigating the risk of
exercise-related cardiovascular events. There is also a lack
of consensus among major organizations regarding the ex-
tent of medical evaluation needed as part of the exercise
preparticipation health screening process (2). The American
College of Cardiology/American Heart Association rec-
ommend exercise testing before engaging in moderate- or
vigorous-intensity exercise when the risk of CVD is in-
creased but recognize that these recommendations are based
on conflicting evidence and divergent expert opinions (15).
The 2008 Physical Activity Guidelines Advisory Committee
report to the Secretary of Health and Human Services (44)
states that ‘‘symptomatic persons or those with CVD, dia-
betes, or other active chronic conditions who want to begin
engaging in vigorous physical activity and who have not
already developed a physical activity plan with their health
care provider may wish to do so,’’ but does not mandate
such medical contact. More recently, the U.S. Preventive
Services Task Force recommends against the use of routine
diagnostic resting or exercise electrocardiography as a screen-
ing tool in asymptomatic individuals who are at low risk of
CVD events and concluded that there is insufficient evidence
to evaluate the benefits and harm of exercise testing before
initiating a PA program and did not make specific recommen-
dations regarding the need for exercise testing for individuals
at intermediate and high risk for CVD events (32). The ACSM
does not recommend abandoning all medical evaluation as
part of the exercise preparticipation health screening pro-
cess. Rather, the new recommendations provide guidance to
identify those at highest risk for exercise-related AMI or SCD
for referral to a health care provider to recommend medical
clearance on the basis of their clinical judgment.
Pulmonary disease. Individuals with pulmonary dis-
ease are no longer automatically referred for medical clear-
ance because pulmonary disease does not increase the risks
of nonfatal or fatal cardiovascular complications during
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or immediately after exercise; in fact, it is the associated
inactive and sedentary lifestyle of many patients with pulmo-
nary disease that may increase the risk of these events (23).
However, chronic obstructive pulmonary disease (COPD) and
CVD are often comorbid because of the common risk factor
of smoking, and the presence of COPD in current or former
smokers is an independent predictor of overall cardiovascular
events (13). Thus, careful attention to the presence of signs
and symptoms of cardiovascular and metabolic disease is war-
ranted in individuals with COPD during the exercise pre-
participation health screening process. Nevertheless, despite
this change, the presence of pulmonary or other diseases
remains an important consideration in determining the safest
and most effective exercise prescription.
THE NEW EXERCISE PREPARTICIPATION
HEALTH SCREENING PROCESS ALGORITHM
The new logic model for the exercise preparticipation screen-
ing process is presented in Figure 2. In this model, regularly
physically active asymptomatic individuals without known
cardiovascular (i.e., cardiac, peripheral artery, cerebrovascu-
lar), metabolic (i.e., type 1 or 2 diabetes mellitus), or renal
disease may continue their usual exercise and progress grad-
ually as tolerated according to the accepted ACSM exercise
prescription guidelines (2,19). Physically active asymptom-
atic individuals with known cardiovascular, metabolic, or
renal disease whose health care provider has cleared them to
exercise within the last 12 months do not need to revisit their
health care provider to continue a moderate-intensity exercise
FIGURE 2—Exercise preparticipation health screening logic model for aerobic exercise participation.
§Exercise participation, performing planned, structured physical activity at least 30 min at moderate intensity on at least 3 dIwkj1 for at least the
last 3 months.
*Light-intensity exercise, 30% to G40% HRR or V˙O2R, 2 to G3 METs, 9–11 RPE, an intensity that causes slight increases in HR and breathing.
**Moderate-intensity exercise, 40% to G60% HRR or V˙O2R, 3 to G6 METs, 12–13 RPE, an intensity that causes noticeable increases in HR and
breathing.
***Vigorous-intensity exercise Q60% HRR or V˙O2R, Q6 METs, Q14 RPE, an intensity that causes substantial increases in HR and breathing.
‡CVD, cardiac, peripheral vascular, or cerebrovascular disease.
‡‡Metabolic disease, type 1 and 2 diabetes mellitus.
‡‡‡Signs and symptoms, at rest or during activity; includes pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from ischemia;
shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or
tachycardia; intermittent claudication; known heart murmur; or unusual fatigue or shortness of breath with usual activities.
‡‡‡‡Medical clearance, approval from a health care professional to engage in exercise.
?ACSM Guidelines, see ACSM_s Guidelines for Exercise Testing and Prescription, 9th edition, 2014.
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program, unless they develop resting or exertional symptoms
of cardiovascular, metabolic, or renal disease or experience
a change in health status. Finally, it is recommended that
physically active individuals who develop signs or symptoms
of cardiovascular, metabolic, or renal disease discontinue ex-
ercise and seek medical clearance before resuming exercise of
any intensity.
Physically inactive but otherwise healthy asymptom-
atic persons may begin light- to moderate-intensity exercise
without medical clearance and, in the absence of symptoms,
progress gradually in intensity as recommended by current
ACSM exercise prescription guidelines (2,19). Physically
inactive individuals with known cardiovascular, metabolic,
or renal disease and/or those with signs or symptoms sug-
gestive of these diseases should seek medical clearance be-
fore starting an exercise program, regardless of the intensity.
CONCLUSIONS
There is voluminous evidence that risks of remaining phys-
ically inactive, especially in those with chronic disease, are
substantial (38,45). The new ACSM exercise preparticipation
health screening recommendations emphasize the important
public health message of regular physical activity for all and
seeks to remove unnecessary barriers to adopting andmaintaining
a structured exercise program, a lifestyle embracing habitual
physical activity, or both. The risk for acute exercise-related
cardiovascular events is highest among habitually sedentary
individuals with known or occult CVD who perform unac-
customed vigorous-intensity physical activity. Hence, the new
ACSM exercise preparticipation health screening guidelines
focus on assessing 1) the individual_s current level of physical
activity, 2) presence of signs or symptoms and/or known
cardiovascular, metabolic, or renal disease, and 3) desired
exercise intensity.
In addition, the hazard of exercise-related cardiovascular
events may more likely be reduced by careful attention to a
safe and effective exercise prescription that 1) addresses the
frequency, intensity, time, and type—volume and progres-
sion or FITT-VP principle of exercise prescription, incor-
porating a progressive transitional phase (i.e., 2–3 months),
during which the duration and intensity of exercise are
gradually increased, 2) advocates appropriate warm-up and
cooldown procedures, 3) promotes education of warning
signs/symptoms (e.g., chest pain or pressure, lightheadedness,
heart palpitations/arrhythmias, unusual shortness of breath),
4) encourages sedentary individuals to engage in regular brisk
walking so as to move them out of the least physically fit and
least physically active cohort, and 5) counsels physically in-
active individuals to avoid unaccustomed vigorous- to near
maximal-intensity physical activity (6,17,19,29,37,46).
The new ACSM exercise preparticipation health screening
recommendations are research informed when available and
seek to simplify the process by eliminating the need for medical
clearance and/or exercise testing inmany individuals, especially
when low- to moderate-intensity exercise is contemplated. The
upcoming ACSM_s Guidelines for Exercise Testing and Pre-
scription, 10th edition, will provide updated and expanded
information on the new ACSM exercise preparticipation health
screening process and recommendations.
The Exercise Preparticipation Health Screening Roundtable was
generously supported by the ACSM. Expert panel members included
David M. Buchner, M.D., M.P.H., F.A.C.S.M.; Joanne Eickhoff-
Schemek, Ph.D.; Carol Ewing Garber, Ph.D., F.A.C.S.M.; Barry A.
Franklin, Ph.D., F.A.C.S.M.; Adrian Hutber, Ph.D.; Elizabeth A. Joy,
M.D., M.P.H., F.A.C.S.M.; Gary Liguori, Ph.D., F.A.C.S.M.; Meir Magal,
Ph.D., F.A.C.S.M.; Linda S. Pescatello, Ph.D., F.A.C.S.M.; Deborah
Riebe, Ph.D., F.A.C.S.M.; Thomas Spring, M.S.; Paul D. Thompson,
M.D., F.A.C.S.M.; Walter R. Thompson, Ph.D.; Darren E. R. Warburton,
Ph.D.; and Geoffrey P. Whitfield, Ph.D., F.A.C.S.M. Several ACSM
staff played key advisory, leadership, and administrative roles, in-
cluding Jim Whitehead, Richard Cotton, Katie Feltman, and Jane
Gleason-Senior.
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